Bausch Health Cos Pre-Tax Income 2010-2024 | BHC

Bausch Health Cos pre-tax income from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Bausch Health Cos Annual Pre-Tax Income
(Millions of US $)
2023 $-390
2022 $-129
2021 $-1,024
2020 $-934
2019 $-1,837
2018 $-4,154
2017 $-1,741
2016 $-2,435
2015 $-155
2014 $1,054
2013 $-1,314
2012 $-394
2011 $-18
2010 $-236
2009 $175
Bausch Health Cos Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $-21
2024-06-30 $48
2024-03-31 $-69
2023-12-31 $-7
2023-09-30 $-326
2023-06-30 $79
2023-03-31 $-136
2022-12-31 $-357
2022-09-30 $439
2022-06-30 $-129
2022-03-31 $-82
2021-12-31 $21
2021-09-30 $216
2021-06-30 $-670
2021-03-31 $-591
2020-12-31 $-394
2020-09-30 $75
2020-06-30 $-437
2020-03-31 $-178
2019-12-31 $-1,470
2019-09-30 $-66
2019-06-30 $-179
2019-03-31 $-122
2018-12-31 $-426
2018-09-30 $-300
2018-06-30 $-734
2018-03-31 $-2,694
2017-12-31 $-804
2017-09-30 $-400
2017-06-30 $-242
2017-03-31 $-295
2016-12-31 $-360
2016-09-30 $-1,332
2016-06-30 $-377
2016-03-31 $-366
2015-12-31 $-268
2015-09-30 $-6
2015-06-30 $-65
2015-03-31 $183
2014-12-31 $552
2014-09-30 $377
2014-06-30 $121
2014-03-31 $5
2013-12-31 $-78
2013-09-30 $-1,141
2013-06-30 $-40
2013-03-31 $-55
2012-12-31 $-275
2012-09-30 $-89
2012-06-30 $-17
2012-03-31 $-13
2011-12-31 $-77
2011-09-30 $12
2011-06-30 $44
2011-03-31 $3
2010-12-31 $-134
2010-09-30 $-148
2010-06-30 $39
2010-03-31 $6
2009-12-31 $48
2009-09-30 $48
2009-06-30 $28
2009-03-31 $51
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.439B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00